Patents by Inventor Jonathan Allen Coe

Jonathan Allen Coe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NEUROMODULATION FOR METABOLIC CONDITIONS OR SYNDROMES
    Publication number: 20240138896
    Abstract: According to some embodiments, a method of treating a subject having diabetes or symptoms associated with diabetes is provided. The method includes delivering a neuromodulation catheter within a vessel (e.g., hepatic artery) having surrounding nerves that innervate the liver (e.g., sympathetic nerves of the hepatic plexus). The method may also include modulating (e.g., disrupting, ablating, stimulating) the nerves by mechanical compression, energy delivery, or fluid delivery.
    Type: Application
    Filed: December 29, 2023
    Publication date: May 2, 2024
    Inventors: Bobak Robert Azamian, Jonathan Allen Coe, Scott Bradley Vafai
  • NEUROMODULATION FOR METABOLIC CONDITIONS OR SYNDROMES
    Publication number: 20240130774
    Abstract: According to some embodiments, a method of treating a subject having diabetes or symptoms associated with diabetes is provided. The method includes delivering a neuromodulation catheter within a vessel (e.g., hepatic artery) having surrounding nerves that innervate the liver (e.g., sympathetic nerves of the hepatic plexus). The method may also include modulating (e.g., disrupting, ablating, stimulating) the nerves by mechanical compression, energy delivery, or fluid delivery.
    Type: Application
    Filed: December 29, 2023
    Publication date: April 25, 2024
    Inventors: Bobak Robert Azamian, Jonathan Allen Coe, Scott Bradley Vafai
  • NEUROMODULATION FOR METABOLIC CONDITIONS OR SYNDROMES
    Publication number: 20240130773
    Abstract: According to some embodiments, a method of treating a subject having diabetes or symptoms associated with diabetes is provided. The method includes delivering a neuromodulation catheter within a vessel (e.g., hepatic artery) having surrounding nerves that innervate the liver (e.g., sympathetic nerves of the hepatic plexus). The method may also include modulating (e.g., disrupting, ablating, stimulating) the nerves by mechanical compression, energy delivery, or fluid delivery.
    Type: Application
    Filed: December 29, 2023
    Publication date: April 25, 2024
    Inventors: Bobak Robert Azamian, Jonathan Allen Coe, Scott Bradley Vafai
  • NEUROMODULATION FOR METABOLIC CONDITIONS OR SYNDROMES
    Publication number: 20240130772
    Abstract: According to some embodiments, a method of treating a subject having diabetes or symptoms associated with diabetes is provided. The method includes delivering a neuromodulation catheter within a vessel (e.g., hepatic artery) having surrounding nerves that innervate the liver (e.g., sympathetic nerves of the hepatic plexus). The method may also include modulating (e.g., disrupting, ablating, stimulating) the nerves by mechanical compression, energy delivery, or fluid delivery.
    Type: Application
    Filed: December 29, 2023
    Publication date: April 25, 2024
    Inventors: Bobak Robert Azamian, Jonathan Allen Coe, Scott Bradley Vafai
  • NEUROMODULATION FOR METABOLIC CONDITIONS OR SYNDROMES
    Publication number: 20210145501
    Abstract: According to some embodiments, a method of treating a subject having diabetes or symptoms associated with diabetes is provided. The method includes delivering a neuromodulation catheter within a vessel (e.g., hepatic artery) having surrounding nerves that innervate the liver (e.g., sympathetic nerves of the hepatic plexus). The method may also include modulating (e.g., disrupting, ablating, stimulating) the nerves by mechanical compression, energy delivery, or fluid delivery.
    Type: Application
    Filed: December 1, 2020
    Publication date: May 20, 2021
    Inventors: Bobak Robert Azamian, Jonathan Allen Coe, Scott Bradley Vafai
  • Neuromodulation for metabolic conditions or syndromes
    Patent number: 10856926
    Abstract: According to some embodiments, a method of treating a subject having diabetes or symptoms associated with diabetes is provided. The method includes delivering a neuromodulation catheter within a vessel (e.g., hepatic artery) having surrounding nerves that innervate the liver (e.g., sympathetic nerves of the hepatic plexus). The method may also include modulating (e.g., disrupting, ablating, stimulating) the nerves by mechanical compression, energy delivery, or fluid delivery.
    Type: Grant
    Filed: September 6, 2018
    Date of Patent: December 8, 2020
    Assignee: Metavention, Inc.
    Inventors: Bobak Robert Azamian, Jonathan Allen Coe, Scott Bradley Vafai
  • MODULATION OF TARGETED NERVE FIBERS
    Publication number: 20200197086
    Abstract: According to various embodiments, systems, devices and methods for modulating targeted nerve fibers (e.g., hepatic neuromodulation) are provided. The systems may be configured to access tortuous anatomy of or adjacent hepatic vasculature. The systems may be configured to target nerves within a wall of (e.g., within adventitia surrounding a lumen of) an artery or other blood vessel, such as the common hepatic artery.
    Type: Application
    Filed: December 6, 2019
    Publication date: June 25, 2020
    Inventors: Bobak Robert Azamian, Jonathan Allen Coe, Scott Bradley Vafai
  • Neuromodulation for metabolic conditions or syndromes
    Patent number: 10617460
    Abstract: According to some embodiments, a method of treating a subject having diabetes or symptoms associated with diabetes is provided. The method includes delivering a neuromodulation catheter within a vessel (e.g., hepatic artery) having surrounding nerves that innervate the liver (e.g., sympathetic nerves of the hepatic plexus). The method may also include modulating (e.g., disrupting, ablating, stimulating) the nerves by mechanical compression, energy delivery, or fluid delivery.
    Type: Grant
    Filed: September 6, 2019
    Date of Patent: April 14, 2020
    Assignee: Metavention, Inc.
    Inventors: Bobak Robert Azamian, Jonathan Allen Coe, Scott Bradley Vafai
  • NEUROMODULATION FOR METABOLIC CONDITIONS OR SYNDROMES
    Publication number: 20190388132
    Abstract: According to some embodiments, a method of treating a subject having diabetes or symptoms associated with diabetes is provided. The method includes delivering a neuromodulation catheter within a vessel (e.g., hepatic artery) having surrounding nerves that innervate the liver (e.g., sympathetic nerves of the hepatic plexus). The method may also include modulating (e.g., disrupting, ablating, stimulating) the nerves by mechanical compression, energy delivery, or fluid delivery.
    Type: Application
    Filed: September 6, 2019
    Publication date: December 26, 2019
    Inventors: Bobak Robert Azamian, Jonathan Allen Coe, Scott Bradley Vafai
  • SYSTEMS AND METHODS FOR MODULATNG NERVES OR OTHER TISSUE
    Publication number: 20190069949
    Abstract: According to various embodiments, systems, devices and methods for modulating targeted nerve fibers (e.g., hepatic neuromodulation) or other tissue are provided. The systems may be configured to access tortuous anatomy of or adjacent hepatic vasculature. The systems may be configured to target nerves surrounding (e.g., within adventitia of or within perivascular space of) an artery or other blood vessel, such as the common hepatic artery.
    Type: Application
    Filed: December 3, 2015
    Publication date: March 7, 2019
    Inventors: Anthony Ciro Vrba, Scott Raymond Smith, Bobak Robert Azamian, Scott Bradley Vafai, Jonathan Allen Coe, James G. Hansen, Kevin Robert Hykes, Kelly Justin McCrystle, Rossana Motta, Michael David Perry, Victor Kelvin Sun, Mark Wilson Ian Webster, Eric Robert Reuland
  • NEUROMODULATION FOR METABOLIC CONDITIONS OR SYNDROMES
    Publication number: 20190069942
    Abstract: According to some embodiments, a method of treating a subject having diabetes or symptoms associated with diabetes is provided. The method includes delivering a neuromodulation catheter within a vessel (e.g., hepatic artery) having surrounding nerves that innervate the liver (e.g., sympathetic nerves of the hepatic plexus). The method may also include modulating (e.g., disrupting, ablating, stimulating) the nerves by mechanical compression, energy delivery, or fluid delivery.
    Type: Application
    Filed: September 6, 2018
    Publication date: March 7, 2019
    Inventors: Bobak Robert Azamian, Jonathan Allen Coe, Scott Bradley Vafai
  • Neuromodulation methods to alter glucose levels
    Patent number: 10070911
    Abstract: According to some embodiments, a method of treating a subject having diabetes or symptoms associated with diabetes is provided. The method includes delivering a neuromodulation catheter within a vessel (e.g., hepatic artery) having surrounding nerves that innervate the liver (e.g., sympathetic nerves of the hepatic plexus). The method may also include modulating (e.g., disrupting, ablating, stimulating) the nerves by mechanical compression, energy delivery, or fluid delivery.
    Type: Grant
    Filed: May 19, 2016
    Date of Patent: September 11, 2018
    Assignee: Metavention, Inc.
    Inventors: Bobak Robert Azamian, Jonathan Allen Coe, Scott Bradley Vafai
  • Therapeutic denervation of nerves surrounding a hepatic vessel
    Patent number: 9999461
    Abstract: According to some embodiments, a method of treating a subject having diabetes or symptoms associated with diabetes is provided. The method includes delivering a neuromodulation catheter within a vessel (e.g., hepatic artery) having surrounding nerves that innervate the liver (e.g., sympathetic nerves of the hepatic plexus). The method may also include modulating (e.g., disrupting, ablating, stimulating) the nerves by mechanical compression, energy delivery, or fluid delivery.
    Type: Grant
    Filed: September 30, 2015
    Date of Patent: June 19, 2018
    Assignee: Metavention, Inc.
    Inventors: Bobak Robert Azamian, Jonathan Allen Coe, Scott Bradley Vafai
  • NEUROMODULATION METHODS TO ALTER GLUCOSE LEVELS
    Publication number: 20160262821
    Abstract: According to some embodiments, a method of treating a subject having diabetes or symptoms associated with diabetes is provided. The method includes delivering a neuromodulation catheter within a vessel (e.g., hepatic artery) having surrounding nerves that innervate the liver (e.g., sympathetic nerves of the hepatic plexus). The method may also include modulating (e.g., disrupting, ablating, stimulating) the nerves by mechanical compression, energy delivery, or fluid delivery.
    Type: Application
    Filed: May 19, 2016
    Publication date: September 15, 2016
    Inventors: Bobak Robert Azamian, Jonathan Allen Coe, Scott Bradley Vafai
  • MODULATION OF TARGETED NERVE FIBERS
    Publication number: 20160128767
    Abstract: According to various embodiments, systems, devices and methods for modulating targeted nerve fibers (e.g., hepatic neuromodulation) are provided. The systems may be configured to access tortuous anatomy of or adjacent hepatic vasculature. The systems may be configured to target nerves within a wall of (e.g., within adventitia surrounding a lumen of) an artery or other blood vessel, such as the common hepatic artery.
    Type: Application
    Filed: June 4, 2014
    Publication date: May 12, 2016
    Applicant: Metavention, Inc.
    Inventors: Bobak Robert Azamian, Jonathan Allen Coe, Scott Bradley Vafai, Anthony Ciro Vrba
  • THERAPEUTIC DENERVATION FOR TREATMENT OF DIABETES
    Publication number: 20160120597
    Abstract: According to some embodiments, a method of treating a subject having diabetes or symptoms associated with diabetes is provided. The method includes delivering a neuromodulation catheter within a vessel (e.g., hepatic artery) having surrounding nerves that innervate the liver (e.g., sympathetic nerves of the hepatic plexus). The method may also include modulating (e.g., disrupting, ablating, stimulating) the nerves by mechanical compression, energy delivery, or fluid delivery.
    Type: Application
    Filed: September 30, 2015
    Publication date: May 5, 2016
    Inventors: Bobak Robert Azamian, Jonathan Allen Coe, Scott Bradley Vafai
  • Balloon catheter neuromodulation systems
    Patent number: 9265575
    Abstract: According to some embodiments, a method of treating a subject having diabetes or symptoms associated with diabetes is provided. The method includes delivering a neuromodulation catheter within a vessel (e.g., hepatic artery) having surrounding nerves that innervate the liver (e.g., sympathetic nerves of the hepatic plexus). The method may also include modulating (e.g., disrupting, ablating, stimulating) the nerves by mechanical compression, energy delivery, or fluid delivery.
    Type: Grant
    Filed: November 8, 2013
    Date of Patent: February 23, 2016
    Assignee: Metavention, Inc.
    Inventors: Jonathan Allen Coe, Bobak Robert Azamian, Scott Bradley Vafai
  • Glucose alteration methods
    Patent number: 9149329
    Abstract: According to some embodiments, a method of treating a subject having diabetes or symptoms associated with diabetes is provided. The method includes delivering a neuromodulation catheter within a vessel (e.g., hepatic artery) having surrounding nerves that innervate the liver (e.g., sympathetic nerves of the hepatic plexus). The method may also include modulating (e.g., disrupting, ablating, stimulating) the nerves by mechanical compression, energy delivery, or fluid delivery.
    Type: Grant
    Filed: November 8, 2013
    Date of Patent: October 6, 2015
    Assignee: Metavention, Inc.
    Inventors: Bobak Robert Azamian, Jonathan Allen Coe, Scott Bradley Vafai
  • Modulation of nerves innervating the liver
    Patent number: 9114124
    Abstract: According to some embodiments, a method of treating a subject having diabetes or symptoms associated with diabetes is provided. The method includes delivering a neuromodulation catheter within a vessel (e.g., hepatic artery) having surrounding nerves that innervate the liver (e.g., sympathetic nerves of the hepatic plexus). The method may also include modulating (e.g., disrupting, ablating, stimulating) the nerves by mechanical compression, energy delivery, or fluid delivery.
    Type: Grant
    Filed: December 26, 2014
    Date of Patent: August 25, 2015
    Assignee: Metavention, Inc.
    Inventors: Bobak Robert Azamian, Jonathan Allen Coe, Scott Bradley Vafai
  • Hepatic neuromodulation using microwave energy
    Patent number: 9089542
    Abstract: According to some embodiments, a method of treating a subject having diabetes or symptoms associated with diabetes is provided. The method includes delivering a neuromodulation catheter within a vessel (e.g., hepatic artery) having surrounding nerves that innervate the liver (e.g., sympathetic nerves of the hepatic plexus). The method may also include modulating (e.g., disrupting, ablating, stimulating) the nerves by mechanical compression, energy delivery, or fluid delivery.
    Type: Grant
    Filed: September 25, 2014
    Date of Patent: July 28, 2015
    Assignee: METAVENTION, INC.
    Inventors: Bobak Robert Azamian, Scott Bradley Vafai, Jonathan Allen Coe